Click HERE To Buy Hydroxychloroquine Online ↓

The Historical Journey of Hydroxychloroquine: from Malaria to Lupus

The origins of hydroxychloroquine can be traced to the natural substance quinine, derived from the bark of the Cinchona tree, native to South America. Since the early 17th century, quinine has been utilized for its medicinal properties against malaria, a life-threatening disease caused by parasites transmitted through the bite of infected mosquitoes. The discovery of quinine's antimalarial effect marked a significant advance in the fight against this disease, and it was the primary treatment for malaria for centuries.

As the use of quinine spread globally, the side effects and the need for a more effective and less toxic alternative became increasingly apparent. The bitter taste, tendency to cause cinchonism—a set of symptoms such as headache, dizziness, and tinnitus—and the variability in effectiveness drove scientists to develop synthetic derivatives. One of these derivatives, chloroquine, emerged in the 1930s and displayed substantial antimalarial efficacy. Hydroxychloroquine, developed shortly after and considered less toxic, soon followed as a therapeutic agent. It retained the antimalarial properties of its predecessors while offering better tolerance in patients.

World War Ii and the Quest for Synthetics

During the tumultuous years of the Second World War, the demand for antimalarial drugs surged as soldiers in the Pacific theater were constantly afflicted by malaria. Quinine, the natural remedy derived from the bark of the cinchona tree, was in short supply due to the Japanese occupation of key production areas. This scarcity prompted a significant push by Allied scientists and pharmaceutical companies to synthesize an effective alternative. The urgency of the war effort accelerated research and development, leading to the creation of chloroquine and its less toxic derivative, hydroxychloroquine.

The innovative formulation of hydroxychloroquine represented a breakthrough in medicinal chemistry. Its synthetic nature meant that it could be produced on a large scale, independent of the cinchona supply and without the limitations imposed by the natural harvesting process. Equally important, hydroxychloroquine had a better safety profile and fewer side effects than its predecessors, making it more suitable for widespread use among troops. With these advancements, hydroxychloroquine became a critical weapon in the fight against malaria, saving countless lives and setting the stage for its eventual role in treating autoimmune diseases.

Hydroxychloroquine's Rise as an Antimalarial Champion

Hydroxychloroquine, a derivative of chloroquine, quickly became a drug of choice for malaria prophylaxis and treatment due to its improved therapeutic profile. Its effectiveness was rooted in its ability to inhibit the replication of the malaria parasite in human red blood cells. The widespread use of hydroxychloroquine during the 1950s and 1960s largely contributed to the containment of malaria outbreaks, particularly in areas where the disease was endemic. This period marked significant strides in antimalarial therapy, and hydroxychloroquine stood out for its reduced toxicity and fewer side effects compared to its predecessors.

Prophylactic use of hydroxychloroquine in soldiers during the Vietnam War further cemented its status as a frontline antimalarial medication. It was found to be exceptionally effective in preventing malaria in troops stationed in regions where the disease was rampant. Moreover, the drug's capability to provide a high level of protection against different strains of the malaria parasite, including those resistant to chloroquine, emboldened its position in antimalarial pharmacology. As research continued, its potential application for chronic autoimmune diseases began to unfold, setting the stage for hydroxychloroquine's future medical relevance beyond its antimalarial genesis.

Beyond Malaria: Uncovering Autoimmunity Applications

Hydroxychloroquine's anti-inflammatory and immunomodulatory effects opened a new chapter in the treatment of autoimmune diseases. As researchers delved deeper into the drug’s mechanisms, they discovered its potential to modulate the immune system without the full-scale suppression caused by other medications. This ability to temper the immune response proved pivotal in managing conditions where the body’s defense systems erroneously attack its own tissues. Initial observational studies and later randomized clinical trials began to highlight the drug's efficacy, leading to its consideration as a cornerstone in the management of certain autoimmune conditions.

Its application soon extended to diseases like rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), where hydroxychloroquine demonstrated a capacity to alleviate symptoms, reduce disease flares, and improve long-term outcomes. In SLE, its use became especially significant, aligning with the need for therapies that could manage the disease with fewer side effects. The drug's ability to decrease the risk of SLE flares and the potential benefits on lipid profiles and diabetes prevention further cemented its role as an invaluable tool in the autoimmune therapeutic arsenal.

The Lupus Breakthrough: a New Therapeutic Hope

Hydroxychloroquine's repositioning to treat autoimmune conditions marked a significant milestone in the late 20th century. Its discovery as a potent anti-inflammatory agent capable of modifying disease activity provided a beacon of hope for lupus patients. The drug was found to mitigate flares and improve skin lesions, offering a better quality of life for those suffering from systemic lupus erythematosus (SLE), a chronic and potentially life-threatening condition. This serendipitous expansion of hydroxychloroquine's therapeutic applications illustrated the drug's versatility and opened new avenues for autoimmune disease management.

The transition of hydroxychloroquine from an antimalarial to a cornerstone in lupus treatment protocols stemmed from its immunomodulatory effects, which can help reduce the risk of flares and organ damage over time. Rigorous clinical trials validated its safety and efficacy for long-term use, solidifying its role in the standard care regimen. The compound's ability to accumulate preferentially in tissues like the skin and kidney made it especially beneficial for lupus patients, as these organs are often affected by the disease. This adaptation of hydroxychloroquine underscored the evolving understanding and innovative repurposing of existing drugs in medicine.

Hydroxychloroquine Today: Controversies and Current Use

Hydroxychloroquine, a drug with a storied past in the treatment of malaria and autoimmune diseases like lupus, has found itself at the center of contemporary controversy. The medication was thrust into the limelight during the COVID-19 pandemic when it was proposed as a potential treatment, causing a global surge in demand and subsequent debates over its efficacy and safety in this context. Despite extensive studies, hydroxychloroquine did not emerge as a standard treatment for COVID-19, leading to a polarization of public opinion and heightened scrutiny of its use, prescription practices, and the potential for political interference in scientific discourse.

Currently, hydroxychloroquine remains an essential medicine for the ongoing management of chronic conditions such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. Its anti-inflammatory properties continue to alleviate symptoms for patients with these conditions, and it is widely appreciated for its relatively benign side effect profile compared to other immunosuppressive medications. Still, healthcare providers must navigate the lingering ambiguities from its moment in the political spotlight, ensuring its application is guided by solid clinical evidence to maintain the trust of the medical community and their patients.

Elite Platinum

Double Platinum





Orthopaedic Summit

35 Mayflower Avenue
Unit B
Stamford, CT 06906
Phone +1 (212) 987-OSET (6738)



Follow Us

For the latest news and announcements follow the Orthopaedic Summit social media pages.


13th Orthopaedic Summit 2023
Boston Marriott Copley Place
Wednesday, September 19 – Saturday, September 23, 2023

Please click here if you need to reset your password.